Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Editor's Note: Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer.

Schiff BA, McMurphy AB, Jasser SA, Younes MN, Doan D, Yigitbasi OG, Kim S, Zhou G, Mandal M, Bekele BN, Holsinger FC, Sherman SI, Yeung SC, El-Naggar AK, Myers JN.

Clin Cancer Res. 2019 Aug 1;25(15):4862. doi: 10.1158/1078-0432.CCR-19-2052. No abstract available.

PMID:
31371312
2.

Editor's Note: Identification of Insulin-Like Growth Factor Binding Protein-3 as a Farnesyl Transferase Inhibitor SCH66336-Induced Negative Regulator of Angiogenesis in Head and Neck Squamous Cell Carcinoma.

Oh SH, Kim WY, Kim JH, Younes MN, El-Naggar AK, Myers JN, Kies M, Cohen P, Khuri F, Hong WK, Lee HY.

Clin Cancer Res. 2019 Aug 1;25(15):4861. doi: 10.1158/1078-0432.CCR-19-2054. No abstract available.

PMID:
31371311
3.

Dual inhibition of epidermal growth factor receptor and insulin-like growth factor receptor I: reduction of angiogenesis and tumor growth in cutaneous squamous cell carcinoma.

Galer CE, Corey CL, Wang Z, Younes MN, Gomez-Rivera F, Jasser SA, Ludwig DL, El-Naggar AK, Weber RS, Myers JN.

Head Neck. 2011 Feb;33(2):189-98. doi: 10.1002/hed.21419.

4.

Branchiogenic carcinoma of a first branchial cleft cyst.

Roche JP, Younes MN, Funkhouser WK, Weissler MC.

Otolaryngol Head Neck Surg. 2010 Jul;143(1):167-8, 168.e1. doi: 10.1016/j.otohns.2010.01.031. Epub 2010 Apr 24. No abstract available.

PMID:
20620640
5.

Recent advances in thyroid cancer.

Grubbs EG, Rich TA, Li G, Sturgis EM, Younes MN, Myers JN, Edeiken-Monroe B, Fornage BD, Monroe DP, Staerkel GA, Williams MD, Waguespack SG, Hu MI, Cote G, Gagel RF, Cohen J, Weber RS, Anaya DA, Holsinger FC, Perrier ND, Clayman GL, Evans DB.

Curr Probl Surg. 2008 Mar;45(3):156-250. doi: 10.1067/j.cpsurg.2007.12.010. No abstract available.

PMID:
18346477
6.

Recent advances in thyroid cancer. In brief.

Grubbs EG, Rich TA, Li G, Sturgis EM, Younes MN, Myers JN, Edeiken-Monroe B, Fornage BD, Monroe DP, Staerkel GA, Williams MD, Waguespack SG, Hu MI, Cote G, Gagel RF, Cohen J, Weber RS, Anaya DA, Holsinger FC, Perrier ND, Clayman GL, Evans DB.

Curr Probl Surg. 2008 Mar;45(3):149-51. doi: 10.1067/j.cpsurg.2007.12.008. No abstract available.

PMID:
18346476
7.

Reciprocal negative regulation between S100A7/psoriasin and beta-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity.

Zhou G, Xie TX, Zhao M, Jasser SA, Younes MN, Sano D, Lin J, Kupferman ME, Santillan AA, Patel V, Gutkind JS, Ei-Naggar AK, Emberley ED, Watson PH, Matsuzawa SI, Reed JC, Myers JN.

Oncogene. 2008 Jun 5;27(25):3527-38. doi: 10.1038/sj.onc.1211015. Epub 2008 Jan 28.

PMID:
18223693
8.

Addressing the impact of foster care on biological children and their families.

Younes MN, Harp M.

Child Welfare. 2007 Jul-Aug;86(4):21-40.

PMID:
17953326
9.

The tyrosine kinase inhibitor, AZD2171, inhibits vascular endothelial growth factor receptor signaling and growth of anaplastic thyroid cancer in an orthotopic nude mouse model.

Gomez-Rivera F, Santillan-Gomez AA, Younes MN, Kim S, Fooshee D, Zhao M, Jasser SA, Myers JN.

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4519-27.

10.

Sorafenib inhibits the angiogenesis and growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice.

Kim S, Yazici YD, Calzada G, Wang ZY, Younes MN, Jasser SA, El-Naggar AK, Myers JN.

Mol Cancer Ther. 2007 Jun;6(6):1785-92.

11.

Effects of the integrin-linked kinase inhibitor QLT0267 on squamous cell carcinoma of the head and neck.

Younes MN, Yigitbasi OG, Yazici YD, Jasser SA, Bucana CD, El-Naggar AK, Mills GB, Myers JN.

Arch Otolaryngol Head Neck Surg. 2007 Jan;133(1):15-23.

PMID:
17224516
12.
13.

Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.

Wang Z, Chakravarty G, Kim S, Yazici YD, Younes MN, Jasser SA, Santillan AA, Bucana CD, El-Naggar AK, Myers JN.

Clin Cancer Res. 2006 Aug 1;12(15):4755-65.

14.
15.

Identification of insulin-like growth factor binding protein-3 as a farnesyl transferase inhibitor SCH66336-induced negative regulator of angiogenesis in head and neck squamous cell carcinoma.

Oh SH, Kim WY, Kim JH, Younes MN, El-Naggar AK, Myers JN, Kies M, Cohen P, Khuri F, Hong WK, Lee HY.

Clin Cancer Res. 2006 Jan 15;12(2):653-61. Erratum in: Clin Cancer Res. 2019 Aug 1;25(15):4861.

16.

Cetuximab and irinotecan interact synergistically to inhibit the growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice.

Kim S, Prichard CN, Younes MN, Yazici YD, Jasser SA, Bekele BN, Myers JN.

Clin Cancer Res. 2006 Jan 15;12(2):600-7.

17.

Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer.

Younes MN, Kim S, Yigitbasi OG, Mandal M, Jasser SA, Dakak Yazici Y, Schiff BA, El-Naggar A, Bekele BN, Mills GB, Myers JN.

Mol Cancer Ther. 2005 Aug;4(8):1146-56.

18.

Antivascular therapy of human follicular thyroid cancer experimental bone metastasis by blockade of epidermal growth factor receptor and vascular growth factor receptor phosphorylation.

Younes MN, Yigitbasi OG, Park YW, Kim SJ, Jasser SA, Hawthorne VS, Yazici YD, Mandal M, Bekele BN, Bucana CD, Fidler IJ, Myers JN.

Cancer Res. 2005 Jun 1;65(11):4716-27.

19.

The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells.

Mandal M, Kim S, Younes MN, Jasser SA, El-Naggar AK, Mills GB, Myers JN.

Br J Cancer. 2005 May 23;92(10):1899-905.

20.

AEE788, a dual tyrosine kinase receptor inhibitor, induces endothelial cell apoptosis in human cutaneous squamous cell carcinoma xenografts in nude mice.

Park YW, Younes MN, Jasser SA, Yigitbasi OG, Zhou G, Bucana CD, Bekele BN, Myers JN.

Clin Cancer Res. 2005 Mar 1;11(5):1963-73.

21.

Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer.

Schiff BA, McMurphy AB, Jasser SA, Younes MN, Doan D, Yigitbasi OG, Kim S, Zhou G, Mandal M, Bekele BN, Holsinger FC, Sherman SI, Yeung SC, El-Naggar AK, Myers JN.

Clin Cancer Res. 2004 Dec 15;10(24):8594-602. Erratum in: Clin Cancer Res. 2019 Aug 1;25(15):4862.

22.

Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade.

Yigitbasi OG, Younes MN, Doan D, Jasser SA, Schiff BA, Bucana CD, Bekele BN, Fidler IJ, Myers JN.

Cancer Res. 2004 Nov 1;64(21):7977-84.

23.

Melanoma of the head and neck: current concepts in staging, diagnosis, and management.

Younes MN, Myers JN.

Surg Oncol Clin N Am. 2004 Jan;13(1):201-29. Review.

PMID:
15062370
24.

Epidermal growth factor receptor blockade potentiates apoptosis mediated by Paclitaxel and leads to prolonged survival in a murine model of oral cancer.

Holsinger FC, Doan DD, Jasser SA, Swan EA, Greenberg JS, Schiff BA, Bekele BN, Younes MN, Bucana CD, Fidler IJ, Myers JN.

Clin Cancer Res. 2003 Aug 1;9(8):3183-9.

25.

[Retrocervical cystic hygroma. Ultrasonic diagnosis. Apropos of 5 cases].

Chelli H, Ben Younes MN, Zouari-Touhami F, Soussi MN, Dellagi K, Boubaker S, Kharouf M.

J Gynecol Obstet Biol Reprod (Paris). 1988;17(2):175-81. French.

PMID:
3290319

Supplemental Content

Loading ...
Support Center